SynthesisNature reviews. Drug discovery2020
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.
Lauren Mifflin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
269 papers cite itlatest 60 shown
this paperpooled ittrialcites it